Bastos Carlos A P, Faria Nuno, Ivask Angela, Bondarenko Olesja M, Kahru Anne, Powell Jonathan
Biomineral Research Group, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK.
Biomineral Research Group, Department of Mineral Science and Technology, MRC Elsie Widdowson Laboratory, Fulbourn Road, Cambridge, CB1 9NL, UK.
Nanoscale Res Lett. 2018 Apr 19;13(1):111. doi: 10.1186/s11671-018-2520-7.
Bacterial resistance to antimicrobial therapies is an increasing clinical problem. This is as true for topical applications as it is for systemic therapy. Topically, copper ions may be effective and cheap antimicrobials that act through multiple pathways thereby limiting opportunities to bacteria for resistance. However, the chemistry of copper does not lend itself to facile formulations that will readily release copper ions at biologically compatible pHs. Here, we have developed nanoparticulate copper hydroxide adipate tartrate (CHAT) as a cheap, safe, and readily synthesised material that should enable antimicrobial copper ion release in an infected wound environment.First, we synthesised CHAT and showed that this had disperse aquated particle sizes of 2-5 nm and a mean zeta potential of - 40 mV. Next, when diluted into bacterial medium, CHAT demonstrated similar efficacy to copper chloride against Escherichia coli and Staphylococcus aureus, with dose-dependent activity occurring mostly around 12.5-50 mg/L of copper. Indeed, at these levels, CHAT very rapidly dissolved and, as confirmed by a bacterial copper biosensor, showed identical intracellular loading to copper ions derived from copper chloride. However, when formulated at 250 mg/L in a topically applied matrix, namely hydroxyethyl cellulose, the benefit of CHAT over copper chloride was apparent. The former yielded rapid sustained release of copper within the bactericidal range, but the copper chloride, which formed insoluble precipitates at such concentration and pH, achieved a maximum release of 10 ± 7 mg/L copper by 24 h.We provide a practical formulation for topical copper-based antimicrobial therapy. Further studies, especially in vivo, are merited.
细菌对抗菌疗法的耐药性是一个日益严重的临床问题。局部应用和全身治疗都是如此。在局部应用方面,铜离子可能是有效且廉价的抗菌剂,其通过多种途径发挥作用,从而限制了细菌产生耐药性的机会。然而,铜的化学性质使其难以制成在生物相容性pH值下能轻易释放铜离子的简易制剂。在此,我们开发了纳米颗粒状的己二酸酒石酸氢氧化铜(CHAT),它是一种廉价、安全且易于合成的材料,有望在感染伤口环境中实现抗菌铜离子的释放。首先,我们合成了CHAT,并表明其水合颗粒分散尺寸为2 - 5纳米,平均zeta电位为 - 40 mV。接下来,当稀释到细菌培养基中时,CHAT对大肠杆菌和金黄色葡萄球菌显示出与氯化铜相似的功效,剂量依赖性活性大多发生在约12.5 - 50 mg/L的铜浓度附近。事实上,在这些浓度下,CHAT非常迅速地溶解,并且正如细菌铜生物传感器所证实的,其细胞内负载与源自氯化铜的铜离子相同。然而,当以250 mg/L的浓度配制在局部应用基质(即羟乙基纤维素)中时,CHAT相对于氯化铜的优势就很明显了。前者在杀菌范围内实现了铜的快速持续释放,但氯化铜在这种浓度和pH值下形成不溶性沉淀,到24小时时铜的最大释放量为10±7 mg/L。我们提供了一种用于局部铜基抗菌治疗的实用制剂。值得进行进一步的研究,尤其是体内研究。